Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. - Wikidata - awgldk - TriplyDB

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

http://www.wikidata.org/entity/Q34519895

about

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis Proton pump inhibitors and gastritis Gastro-esophageal reflux disease in healthy older children and adolescents Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review A review of stress-related mucosal disease Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach Consensus Statement for Standard of Care in Spinal Muscular Atrophy Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing.Nitric oxide antagonizes the acid tolerance response that protects Salmonella against innate gastric defenses.Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole.Perils and pitfalls of long-term effects of proton pump inhibitors.Gastrointestinal motility disorders in children Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants.Use of ranitidine is associated with infections in newborns hospitalized in a neonatal intensive care unit: a cohort study Infection-related asthma.Risk of fracture and pneumonia from acid suppressive drugs.Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.Adverse effects of long-term proton pump inhibitor therapy.Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009 Anti-acid medication as a risk factor for food allergy.The systems biology of infection in animal models bears fruit Clinical practice guideline: hoarseness (dysphonia).Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies.Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals Integrative Treatment of Reflux and Functional Dyspepsia in Children Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth.Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients.Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis.Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.Review article: methods of measuring gastric acid secretion.Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review.Gastroesophageal reflux disease in children and adolescents: when and how to treat.Inhibitors of gastric acid secretion drugs increase neonatal morbidity and mortality.

P2860

Q22241389-9C4B612B-E2B7-4708-A6D1-8050E338B981 Q24655315-9656FAD0-14EB-4019-8C47-48FFDF886CC6 Q26860927-83B29490-AEEB-4B63-BEEF-EA946F09C9CF Q28072141-6EEB300B-AD57-4E9F-A507-A69DCC2204E0 Q28082238-635B3308-7338-4195-A78D-ED8250CD01A1 Q28259245-01ED8E48-ACC3-4674-8916-302F5CC69EC9 Q28555174-C59C429D-2783-4645-BE4E-FD59297ECB7A Q29028573-D3C3FD45-DF3E-4807-82E0-69C85EB2B027 Q30300235-D16D8D25-2A73-4EFC-871D-491D868F119B Q30399991-58F2A976-7309-48D2-9467-1A43DAD8C266 Q33324409-F3324E74-144A-4CD9-BCCD-0D72CD18AF02 Q33338273-829FFA49-94A2-4994-9E96-31F4523FBD3B Q33409626-97E4E318-4500-4771-93BF-575C7AEA215F Q33561975-B9931721-FAA5-44ED-9A88-76950A18205C Q33584890-D8E0D4F9-41D0-4398-BA61-B50535753A4F Q33742768-A54D0D7A-CC12-4E86-86BB-32782EAE193C Q33917155-F1E9CA11-3BFB-4DB8-BACF-AFCDF7FDF1E9 Q34092977-144BD544-C62F-443A-89BD-D7917B3B3ACD Q34127482-2DBF04F2-7361-4942-939D-6BC8F121D34C Q34167899-32305E0D-4D08-435B-AB98-EA00CE81E64E Q34589801-07E3F893-82A5-4C21-A834-CEE6B5FFE833 Q34625515-DE4AC293-8EC1-4F49-861A-E8F45BEFECA9 Q34686906-7884817F-65DE-47D2-8423-EE6DD48707EC Q35001102-BF20846E-2C5C-4FD6-AC20-23886574854D Q35178642-45D7C0A3-FF9B-4723-8091-84D577465BB1 Q35235645-2ACA4283-F206-4EC3-AC61-F37C7A4E9B9A Q35683435-76A91D82-9569-402C-91AD-87D9A87EED69 Q35865246-7DED8688-66DB-459C-8EE6-32FD04E6DBDE Q37047798-C4F208AE-8375-4081-8917-B66377746A75 Q37055804-2F504DA7-0EB3-40F5-8279-ABF6D7F2031A Q37378692-2A44ACBC-2EF9-4665-A328-C48D7579C9D2 Q37402038-89F9DF15-ADF4-49F7-87A1-061A1BD89C14 Q37481108-0C5A6D4E-EE1E-47D6-8FEB-BE345C244591 Q37561598-39E28D7C-B09B-432B-B660-CB5E6B55BAA1 Q37731243-C73E4EA3-51B1-4F22-A991-E4D525513B0E Q37808356-0E7FC734-0F15-4B1F-B2C8-6BEC518C0FE1 Q37831951-3FD39894-B115-4784-93FD-DEFB32FB5444 Q37892887-0BBC7696-6F17-47B0-95C7-DDA455505E19 Q37960158-586AE32C-8F4D-418D-8A36-D711141AC5F4 Q38041609-CEB7E5B9-DBAE-4E6C-9370-F782CC0A9B0A

P2860

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

http://www.wikidata.org/entity/Q34519895

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Therapy with gastric acidity i ...... cquired pneumonia in children.

@ast

Therapy with gastric acidity i ...... cquired pneumonia in children.

@en

Therapy with gastric acidity i ...... cquired pneumonia in children.

@nl

type

label

Therapy with gastric acidity i ...... cquired pneumonia in children.

@ast

Therapy with gastric acidity i ...... cquired pneumonia in children.

@en

Therapy with gastric acidity i ...... cquired pneumonia in children.

@nl

prefLabel

Therapy with gastric acidity i ...... cquired pneumonia in children.

@ast

Therapy with gastric acidity i ...... cquired pneumonia in children.

@en

Therapy with gastric acidity i ...... cquired pneumonia in children.

@nl

P1433

Q34519895-2104D93A-A6E0-493D-98E4-E39875A7CE59

P1476

Q34519895-D2BFCC41-36E0-49FE-8687-E5ECFB5959D8

P2093

Q34519895-0B4ED6A7-9E47-421B-ACE9-F9974323C252

Q34519895-2AA2BA18-7D12-4576-8ACB-5A7B756E0EB0

Q34519895-2B6895CA-4119-4349-B6D1-AAAD8E35737B

Q34519895-4AB16512-F9C1-43DA-815C-E152F0AFC5AA

Q34519895-5D0E82CB-B2E7-4876-962C-6629C7F61B86

Q34519895-95B8530A-00DA-44DB-A2E6-63FB14F688FB

Q34519895-EA5ECEF0-87CA-4E6E-A1EA-39D6C1B76710

P304

Q34519895-1800DBA0-691D-4248-8AF7-E52C4F11256C

P31

Q34519895-01407320-D19B-4B44-A631-C89170C8612A

P356

Q34519895-24C33F8D-D578-4FF7-9E9C-A929FA0C8CDE

P407

Q34519895-1F28D112-582A-489F-BC3D-71A5D36F3223

P433

Q34519895-777BD38B-CB96-4C5B-9C26-77E390D8FCF3

P478

Q34519895-5EA259CB-9F69-4E0D-BA0B-5D0C106615BC

P50

Q34519895-01BBBC65-6DF0-41BA-9466-8C6A98A994FE

Q34519895-0EF65E20-946D-4896-848A-C8CBCEFBD26A

Q34519895-D49231D2-20C8-4114-9CC9-1371C18948E4

Q34519895-E741A095-2AFE-4647-8ECB-40CCCA0E3DFB

P577

Q34519895-6A8DD839-5ED3-42D9-9E64-666C690D1457

P5875

Q34519895-34E3144E-DCAB-4281-B348-8B2F0872C544

P698

Q34519895-4D418ECC-FA1D-408B-8D58-AE9BB09171C9

P921

Q34519895-202A804B-639C-4F39-980E-713B971A72F6

Q34519895-4EAF2931-8130-42A6-8D6D-6328979AB517

P356

P1433

P1476

Therapy with gastric acidity i ...... cquired pneumonia in children.

@en

P2093

Alfredo Guarino

http://www.w3.org/2001/XMLSchema#string

Annalisa Passariello

http://www.w3.org/2001/XMLSchema#string

Basilio Malamisura

http://www.w3.org/2001/XMLSchema#string

Francesco Manguso

http://www.w3.org/2001/XMLSchema#string

Paola Roggero

http://www.w3.org/2001/XMLSchema#string

Pia Cirillo

http://www.w3.org/2001/XMLSchema#string

Working Group on Intestinal In ...... atology and Nutrition (SIGENP)

http://www.w3.org/2001/XMLSchema#string

P304

e817-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2005-1655

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Berni Canani

Gianluca Terrin

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7130689

http://www.w3.org/2001/XMLSchema#string

P698

16651285

http://www.w3.org/2001/XMLSchema#string

P921

gastroenteritis